multi-morbidness + multi-pharma therapies must be a real challenge for a) treating current patients and b) performing RCTs on new treatments. Then toss in unique human genetics variables.......

Treating folks and and measuring objective outcomes ain't for sissies (or bought and paid for gov agencies!).